M&AHealthcareSIGNED
Novartis signs $7.8 billion drug deal with Chinese startup
Value
$7.8Bn
Acquirer
Novartis
Target
Chinese startup
Novartis has entered into a drug deal worth $7.8 billion with a Chinese startup. The specifics of the drug or the startup were not detailed in the headline.
The Meridian Weekly
The week's largest deals and the Iberian ones, every Monday. Free.